Benzinga's Volume Movers

ACADIA Pharmaceuticals Inc ACAD shares moved up 46.93% to $11.71 at 10:54 am. The volume of ACADIA Pharmaceuticals shares traded was 1410% % higher than normal. ACADIA Pharmaceuticals announced following its FDA meeting, it no longer needs to conduct additional Phase III trials for its pimavanserin drug for the treatment of Parkinson's disease psychosis. The company plans to seek early approval for the drug. Zumiez Inc ZUMZ shares climbed 16.47% to $29.002. The volume of Zumiez shares traded was 596% higher than normal. Zumiez reported a 2.1% jump in comparable store sales for the 5-weeks ended Apr 6, 2013. ReachLocal, Inc RLOC shares gained 3.5% to $15.68. The volume of ReachLocal shares traded was 501% higher than normal. ReachLocal announced that it will report its 1Q 2013 results for the period ended March 31, 2013 after market close on May 7, 2013. Proto Labs, Inc PRLB shares rose 5.59% to $55.15. The volume of Proto Labs shares traded was 386% higher than normal. Proto Labs' trailing twelve month profit margin is 19.07%.